Market Place
Sourcing Support
Spero Announces First Patient, First Visit for Ph 3 Trial Evaluating Tebipenem
02 Jan 2024 //
GLOBENEWSWIRE
Spero Therapeutics Announces Agreement with FDA for Phase 3 of Tebipenem HBr
31 Jul 2023 //
GLOBENEWSWIRE
Spero Therapeutics Tebipenem Pivoxil Hydrobromide Phase 3 Data Published
06 Apr 2022 //
GLOBENEWSWIRE
Spero Awarded up to $54 M by BARDA and DTRA to Support SPR994 Development
16 Jul 2018 //
PRESS RELEASE
Spero Announces Positive Interim Phase 1 SAD/MAD Results for SPR994
09 Jul 2018 //
PRESS RELEASE
Successful USFDA inspection of Asymchem manufacturing facility
02 Jun 2018 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.